Washington, DC 20549





to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of report (Date of earliest event reported):

April 12, 2018



(Exact Name of Registrant as Specified in Its Charter)


New York





(State or Other Jurisdiction of Incorporation or Organization)


(Commission File Number)


(IRS Employer Identification No.)


355 South Technology Drive

Central Islip, New York




(Address of Principal Executive Offices)


(Zip Code)


Registrant’s Telephone Number, Including Area Code: (631) 981-7081



(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐     


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On April 12, 2018, the Board of Directors (the “Board”) of CVD Equipment Corporation (the “Company”) elected Dr. Robert M. Brill to serve as a director of the Company, expanding its Board to six directors, effective as of April 16, 2018. Dr. Brill was also elected to serve on the Board’s Nominating, Governance and Compliance Committee, Audit Committee, and Compensation Committee.


Dr. Brill is co-founder and managing partner of Newlight Management, which manages venture capital funds that focus on early stage technology companies. Prior to co-founding Newlight, Dr. Brill was a general partner of Poly Ventures, a Long Island based venture capital fund. Dr. Brill is a member of the Board of Directors of the L.I. Angel Network, the L.I. High Tech Incubator and several private companies. Dr. Brill has also previously served on the Board of Directors of multiple public and private companies. Dr. Brill served as General Manager of Harris Corporation’s CMOS Semiconductor Division. He also held various technical and management positions at IBM’s semiconductor operation. Dr. Brill holds a Ph.D in nuclear physics from Brown University and a B.A. and a B.S. in Engineering Physics from Lehigh University.


There is no arrangement or understanding between Dr. Brill and any other persons pursuant to which Dr. Brill was elected as a director. The Company believes that Dr. Brill is qualified to serve as a director of the Company because of his extensive background and experience serving and advising technology companies.


Dr. Brill will receive compensation as a director in accordance with the Company’s Director Compensation Plan applicable to all non-employee directors described in the Company’s 2017 Proxy Statement filed with the U.S. Securities and Exchange Commission on October 5, 2017.


Item 8.01

Other Events.


On April 17, 2018, the Company issued a press release reporting the appointment of Dr. Brill as a director. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.


Item 9.01

Financial Statements and Exhibits


(d) Exhibits


Exhibit No.     Description


99.1          Press Release dated April 17, 2018







Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date:  April 17, 2018









/s/ Leonard A. Rosenbaum



Leonard A. Rosenbaum



Chairman, President and Chief Executive Officer